clearance clinical pharmacokinetics cytochrome P450

Journal

Drug metabolism and disposition: the biological fate of chemicals
ISSN: 1521-009X
Titre abrégé: Drug Metab Dispos
Pays: United States
ID NLM: 9421550

Informations de publication

Date de publication:
01 Jun 2021
Historique:
accepted: 15 04 2021
received: 21 12 2020
revised: 24 03 2021
pubmed: 3 6 2021
medline: 3 6 2021
entrez: 2 6 2021
Statut: aheadofprint

Résumé

Characterizing the pharmacokinetic properties of drug candidates represents an essential task during drug development. In the past, liver microsomes and primary suspended hepatocytes have been extensively used for this purpose, but their relatively short stability limits the applicability of such

Identifiants

pubmed: 34074732
pii: dmd.120.000340
doi: 10.1124/dmd.120.000340
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.

Auteurs

Julia Riede (J)

Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, Switzerland.

Birgit M Wollmann (BM)

Diakonhjemmet Hospital, Norway.

Espen Molden (E)

Dept. of Pharmacology, University of Oslo, Norway.

Magnus Ingelman-Sundberg (M)

Department of Physiology and Pharmacology, Karolinska Institutet, Sweden magnus.ingelman-sundberg@ki.se.

Classifications MeSH